Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sedatives and Hypnotics Drugs: Benzodiazepines

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

Anxiolytic Drugs: Benzodiazepines and Buspirone

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...

CNS Depressants: Barbiturates and Benzodiazepines

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.

Sedatives and Hypnotics: Overview

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psilocybin therapy for adult females with anorexia nervosa: pilot study.

The British journal of psychiatry : the journal of mental science·2026

Same author

Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.

Human brain mapping·2026

Same author

Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation.

PloS one·2026

Same author

Towards Mechanism-Informed Treatments for Mental Health.

Journal of neurochemistry·2026

Same author

Exploring new avenues: Psychedelic-assisted therapy for young people.

British journal of clinical pharmacology·2026

Same author

An international mega-analysis of psychedelic drug effects on brain circuit function.

Nature medicine·2026

Search research articles

Related Experiment Videos

Benzodiazepines: risks and benefits. A reconsideration.

David S Baldwin¹, Katherine Aitchison, Alan Bateson

¹1Faculty of Medicine, University of Southampton, Southampton, UK.

Journal of Psychopharmacology (Oxford, England)

|September 27, 2013

Summary

Benzodiazepine use requires careful consideration of risks and benefits. Short-term or intermittent use may offer benefits, but potential dependence and harms must be weighed against underlying condition risks.

Keywords:

Benzodiazepines benefits pharmacology risks withdrawal

Related Experiment Videos

Area of Science:

Psychiatry
Pharmacology

Background:

Recent advancements in understanding benzodiazepine risks and benefits.
Growing concerns regarding benzodiazepine dependence and related drugs.

Purpose of the Study:

To review developments in benzodiazepine and alternative treatments.
To provide joint recommendations for clinical practice.

Main Methods:

A joint statement developed by representatives from the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists and the British Association for Psychopharmacology.
Examination of recent research on benzodiazepines and alternatives.

Main Results:

Benzodiazepines carry risks of dependence and other harmful effects.
Short-term or intermittent benzodiazepine use can provide benefits.

Conclusions:

Clinical practice should consider the potential for dependence with benzodiazepines.
The benefits of short-term benzodiazepine use should be balanced against long-term risks and the severity of underlying conditions.